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Abstract NADPH-dependent reactions play important roles
in production of industrially valuable compounds. In this
study, we used phosphofructokinase (PFK)-deficient strains
to direct fructose-6-phosphate to be oxidized through the
pentose phosphate pathway (PPP) to increase NADPH gener-
ation. pfkA or pfkB single deletion and double-deletion strains
were tested for their ability to produce lycopene. Since lyco-
pene biosynthesis requires many NADPH, levels of lycopene
were compared in a set of isogenic strains, with the pfkA single
deletion strain showing the highest lycopene yield. Using
another NADPH-requiring process, a one-step reduction reac-
tion of 2-chloroacrylate to 2-chloropropionic acid by 2-
haloacrylate reductase, the pfkA pfkB double-deletion strain
showed the highest yield of 2-chloropropionic acid product.
The combined effect of glucose-6-phosphate dehydrogenase
overexpression or lactate dehydrogenase deletion with PFK
deficiency on NADPH bioavailability was also studied. The
results indicated that the flux distribution of fructose-6-
phosphate between glycolysis and the pentose phosphate
pathway determines the amount of NAPDH available for
reductive biosynthesis.
Keywords PFK . NADPH bioavailability . pfkA . pfkB .
G6PDH . E. coli
Introduction
Cofactor pairs, NAD+/NADH and NADP+/NADPH are es-
sential for the growth and energetics of microbial cells.
NADH molecules are oxidized mainly through the electron
transport chain and serve as the source of ATP under aerobic
conditions, while NADPH molecules are mainly oxidized
through anabolic pathway and provide essential reducing
cofactors for macromolecular biosynthesis such as fatty
acids, amino acids, and nucleic acid components. Internal
availability of NADP+/NADPH make microbial cells per-
fect candidates for whole cell catalyzed redox reactions for
the production of industrially valued compounds. However,
the relative composition of the reduced form of NADP+/
NADPH and the overall concentration inside the cells is
tightly controlled and balanced with NAD+/NADH through
pyridine nucleotide transhydrogenase and the biosynthetic
enzymes involved in NAD and NADP synthesis. To utilize
intracellular NADPH as the reducing power to drive redox
reactions, different strategies have been developed and in-
vestigated in Escherichia coli to increase the bioavailability
of NADPH.
The reduced cofactor, NADPH, is mainly generated
through the pentose phosphate pathway (PPP), isocitrate
synthase of the tricarboxylic acid cycle (TCA), and malic
enzyme (Fig. 1). Strategies such as overexpression of zwf,
encoding glucose-6-phosphate dehydrogenase (G6PDH)
(Chin et al. 2009; Kim et al. 2011b; Lee et al. 2007), or
deletion of pgi, encoding phosphoglucose isomerase (Bartek
et al. 2010; Chemler et al. 2010; Kim et al. 2011a), have
been used to increase the metabolic flux to PPP from
glycolysis. Other strategies include overexpression of pyri-
dine nucleotide transhydrogenase encoded by udhA which
converts NADH to NADPH (Sanchez et al. 2006), and
switching the glycolytic enzyme, NAD+ dependent
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) to
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NADP+-dependent GAPDH fromClostridium acetobutylicum
(Martinez et al. 2008).
In this study, we focused on phosphofructokinase which
catalyzes the phosphorylation of fructose-6-phosphate to
fructose-1,6-biphosphate and is the first committed step of
the major glycolytic pathway in bacteria. There are two
isoenzymes of PFK in E. coli, PfkA and PfkB. PfkA has
been reported to contribute 90 % of the PFK activity while
PfkB is the minor enzyme contributing 5–10 % of the
activity (Vinopal et al. 1975). In another study (Siedler et
al. 2011), pfkA mutants showed 23 % of wild-type activity
while pfkB mutants showed 78 % of wild-type activity, with
the double mutant exhibiting 27 % of wild-type activity.
These two enzymes have different kinetic properties, e.g.,
PfkB is little affected by phosphoenolpyruvate levels and
does not show cooperativity in response to fructose-6-
phosphate in contrast to PfkA. It is possible that these
differences in enzyme properties contribute to variation in
metabolism in individual mutant strains under certain con-
ditions. Previous studies have shown that deleting pfkA
alone improved NADPH-dependent xylitol production from
xylose (Chin and Cirino 2011). We are studying the effects
of blocking this step entirely by deleting both PFK genes,
pfkA and pfkB, and consider that disrupting glycolysis at this
point will then force fructose-6-phosphate to undergo the
reversible isomerization reaction that proceeds in the direc-
tion of glucose 6-phosphate. Glucose 6-phosphate will then
enter the PPP, which will generate 2 mol of NADPH per
cycle. Normally, the fructose 6-phosphate resulting from the
non-oxidative stage of PPP will enter glycolysis, but in the
absence of both pfkA and pfkB, theoretically, it will be
converted to glucose 6-phophate and can proceed back to
PPP again, which will lead to more NADPH generation.
This has been recently described as a partial cyclization of
the pentose phosphate pathway (Siedler et al. 2012).
Glyceraldehyde 3-phosphate resulting from PPP will re-
enter the glycolytic pathway and TCA cycle in the end to
generate NADH and ATP. By forcing fructose 6-phosphate
to go through the PPP to be fully oxidized, the overall
theoretical balance will be 1 mol of glucose input with
1 mol of glyceraldehyde 3-phosphate, 3 mol of CO2, and
6 mol of NADPH as output from the steps leading to the
glycolytic intermediate, glyceraldehyde 3-phosphate. Thus,
the maximal NADPH that could be derived from 1 mol of
glucose through this PPP process would be the six derived
from this PPP process plus those derived from GAP metab-
olism, e.g., another NADPH could be derived from the
isocitrate dehydrogenase reaction in the TCA cycle. In ad-
dition, the presence of transhydrogenases may contribute
some via the conversion of NADH from other reactions to
NADPH.
We wanted to assess the effect of rerouting metabolism
on NADPH availability in different circumstances that
would represent situations where such modifications might
be used and would allow the function to be determined in
the context of cellular redox metabolism and with various
products. The systems chosen for analysis of the effects
were: lycopene as a representative of a highly NADPH-
dependent metabolite derived from glycolytic precursors
formed in aerobic cultures and representative of situations
where normal cellular precursors are channeled to a desired
product; and in a controlled anaerobic biocatalyst mode
Fig. 1 Simplified diagram of
glycolysis, TCA cycle, PPP,
and biosynthesis pathway of
lycopene. Abbreviations used
are as follows: G6P glucose-6-
phosphate, F6P fructose-6-
phosphate, G3P
glyceraldehyse-3-phosphate,
PEP phosphoenolpyruvate,
6PG 6-phosphogluconolactone,
RU5P ribulose-5-phosphate,
R5P ribose-5-phosphate, X5P
xylulose-5-phosphate, S7P
sedoheptulose-7-phosphate,
E4P erythrose-4-phosphate,
DHAP dihydroxyactone-3-
phosphate, DXP
deoxyxylulose-5-phosphate,
DMPP dimethylallyl
pyrophosphate, IPP isopentenyl
phosphate
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where we could analyze the total redox of the cell going to
reduced products and assess the contribution of the added
exogenous NADPH-dependent system “sink” in competition
with other redox processes in the cell (e.g., lactate formation).
We examined the PFK-deficient strains in situations
where a product highly dependent on NADPH was being
made. These situations included NADPH-dependent lyco-
pene production and one-step reduction of 2-chloroacrylate
to 2-chloropropionic acid, two compounds that we could
accurately measure as indicators of NADPH use. Lycopene
is a commercially important carotenoid that has antioxidant
activity and other health benefits. Lycopene producing
genes crtEBI from Erwinia herbicola have been expressed
in E. coli and lycopene has been successfully synthesized in
E. coli (Alper et al. 2005b; Yoon et al. 2008). The biosynthesis
of lycopene in E. coli follows the non-mevalonate pathway
that uses the glycolytic intermediate glyceraldehyde-3-
phosphate and pyruvate as precursors and would consume
16 mol of cofactor NADPH for 1 mol of lycopene production
(Alper et al. 2005a).
The one-step reaction module we used to demonstrate
NADPH bioavailability uses 2-haloacrylate reductase
CAA43 from the soil bacteria, Burkholderia sp. WS (Kurata
et al. 2008; Kurata et al. 2005). CAA43 catalyzes reduction of
the carbon–carbon double bond of 2-chloroacrylate to (s)-2-
chloropropionate coupled with NADPH oxidization to
NADP+. This reaction directly reflects the bioavailability of
NADPH in the cells and by supplying enough substrate 2-
chloroacrylate, an ample sink will be provided for the cell to
oxidize extra NADPH, and therefore to maintain redox ho-
meostasis. This also provides an example for the more prac-
tical situation of industrial relevance, where a NADPH-
dependent product is desired to be formed at high levels.
This study showed that deletion of both PFK genes, pfkA
and pfkB, improved bioavailablity of NADPH in the cell as
analyzed by the 2-chloropropionate production system.
Lycopene production was the highest in the pfkA single
deletion strain. Both NADPH-dependent processes were
also studied with overexpression of G6PDH to further in-
crease the PPP flux and by deletion of lactate dehydroge-
nase (ldh) which would prevent NADH consumption by
formation of this fermentation byproduct.
Materials and methods
Bacterial strains and plasmids
Table 1 describes the strains and plasmids used in this study.
For the lycopene production assay, E. coli MQ, RL257,
RL254, and RL255 were transformed with pACLYC carry-
ing carotenoid biosynthesis genes crtE, crtI, and crtB from
E. herbicola. For 2-haloacrylate reductase assay,MQ, RL257,
RL254, and RL255 were transformed with pTrc99A-CAA43,
respectively. G6PDH was overexpressed from plasmid
pASK-IBA-G6PD1. In the case of the 2-haloacrylate reduc-
tase assay, to be compatible with pASK-IBA-G6PD1, the
gene encoding the 2-haloacrylate reductase, CAA43 was
moved from pTrc99A-CAA43 to pDHC29.
The gene encoding the 2-haloacrylate reductase, CAA43
was amplified by PCR from pET101-D-Topo-CAA43 using
primers CAA43-F-NcoI (5′-CCG CCATGG GA ATG GTA
ATG GCA GCG GTA ATT CAT AAG-3′) and CAA43-R-
XbaI (5′-CGC TCTAGA CTA CGC TTG CGG AAG CAA
AAC AAT-3′). The PCR fragment was digested with NcoI
and XbaI and cloned into pTrc99A. To make pDHC29-
CAA43, CAA43 was amplified by PCR using primers
CAA43-F-SacI (5′-CCG GAGCTC C ATG GTA ATG
GCA GCG GTA ATT CAT AAG-3′) and CAA43-R-XbaI,
and cloned into SacI and XbaI digested pDHC29. Both
constructs were then confirmed by DNA sequencing.
Culture medium
M9 minimal medium contains 6.78 g/L of Na2HPO4,
0.5 g/L of NaCl, 1 g/L of NH4Cl, and 3 g/L of KH2PO4
supplemented with 0.2 % of glucose and 1 mM of MgSO4.
Buffered LBmedium is Luria-Bertani (LB) broth supplemented
with 0.1 M sodium phosphate buffer.
2-haloacrylate reductase (CAA43) assay
Test strains were first grown in 5 mL of LB broth overnight
and supplemented with antibiotics such as 100 μg/mL of
ampicillin or 35 μg/mL of chloramphenicol if required.
Overnight culture (1.5 mL) was then inoculated to 150 mL
of fresh LB broth in 500 mL flasks supplemented with
antibiotics and grown in a rotary shaker at 250 rpm and
37 °C. After 3–4 h growth, IPTG was added to make the
concentration 1 mM in each flask to induce expression of
CAA43 from pTrc99A-CAA43. In the case with pASK-
IBA3-G6PD1, 0.2 mg/mL of anhydrotetracycline was added
to induce expression of G6PDH. The induction continued
under the same conditions for 18 h before cells were col-
lected for the subsequent experiments.
After 18 h of induction, equal amount of cells were
collected based on optical density measurements at OD
600 nm. Cell pellets were then washed with minimal medi-
um without nitrogen source and resuspended in 15 mL of
reaction medium. Minimal medium without nitrogen source
contains 6 g/L Na2HPO4, 3 g/L KH2PO4, and 0.5 g/L NaCl.
Reaction medium is minimal medium without nitrogen
source supplemented with 0.1 mM CaCl2, 1 mM MgSO4,
1 mg/mL thiamine, 2 % glucose, 50 mM 2-chloroacrylic
acid, and antibiotics when appropriate. pH of the reaction
medium was adjusted to 7.0 with 6 N HCl.
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After cells were resuspended in reaction medium, around
14.5 mL aliquots of the suspension of each strain were
distributed into 15 mL glass vials. The glass vials were later
closed and sealed with rubber stoppers for anaerobic fer-
mentation. Samples were taken using sterile needle and
syringe at each time point for HPLC analysis.
Lycopene assay
Test strains were first grown in 5 mL of LB broth overnight
at 37 °C. Then 500 μL of the overnight cultures were
inoculated into 50 mL of fresh LB supplemented with 2 %
glucose, 100 mM phosphate buffer (pH7.0) and antibiotics,
when appropriate, and the cultures were grown in 250 mL
flasks in a rotary shaker at 30 °C, 250 rpm. After 24 or 48 h,
10 mL samples from each flask were taken, the cells were
pelleted and washed once with distilled water. The cell
pellets were then resuspended in 5 mL of acetone at 55 °C
for 15 min in the dark to extract lycopene from the cells.
After a 15-min extraction, the solutions were centrifuged at
11,000 rpm for 10 min to remove cell debris (Martinez et al.
2008). The supernatants were then measured for absorbance at
Table 1 Strains and plasmids
Genotype Reference
Strains
MQ F-, [araD139]B/r, lacIp-4000(lacI
Q), e14, flhD5301,
Δ(fruK-yeiR)725(fruA25), relA1, rpsL150(strR),
rbsR22, Δ(fimB-fimE)632(::IS1), deoC1
From CGSC, (Lovingshimer et al. 2006)
RL257 MQ pfkA203(del-ins)::FRT, pfkB205(del-ins)::FRT From CGSC, (Lovingshimer et al. 2006)
RL254 MQ pfkA203(del-ins)::FRT From CGSC, (Lovingshimer et al. 2006)
RL255 MQ pfkB205(del-ins)::FRT From CGSC, (Lovingshimer et al. 2006)
YW8055 MQ pACLYC This study
YW8056 RL257 pACLYC This study
YW8057 RL254 pACLYC This study
YW8058 RL255 pACLYC This study
YW8082 MQ pACLYC pASK-IBA3-G6PD1 This study
YW8083 RL257 pACLYC pASK-IBA3-G6PD1 This study
YW8084 RL254 pACLYC pASK-IBA3-G6PD1 This study
YW8085 RL255 pACLYC pASK-IBA3-G6PD1 This study
YW8051 MQ pTrc99A-CAA43 This study
YW8052 RL257 pTrc99A-CAA43 This study
YW8053 RL254 pTrc99A-CAA43 This study
YW8054 RL255 pTrc99A-CAA43 This study
YW8066 MQ pDHC29-CAA43 This study
YW8067 RL257 pDHC29-CAA43 This study
YW8068 RL254 pDHC29-CAA43 This study
YW8069 RL255 pDHC29-CAA43 This study
YW8070 MQ pDHC29-CAA43 pASK-IBA3-G6PD1 This study
YW8071 RL257 pDHC29-CAA43 pASK-IBA3-G6PD1 This study
YW8072 RL254 pDHC29-CAA43 pASK-IBA3-G6PD1 This study
YW8073 RL255 pDHC29-CAA43 pASK-IBA3-G6PD1 This study
Plasmids
pET101-D-topo-CAA43 CAA43, encoding 2-haloacrylate reductase from
Burkholderia sp. WS, was expressed in
pET101/D-TOPO (Invitrogen), ApR
(Kurata et al. 2005), (Kurata et al. 2008)
pTrc99A-CAA43 CAA43 expressed in pTrc99A, ApR This study
pDHC29 High copy plasmid compatible with pASK-IBA3 (Phillips et al. 2000)
pDHC29-CAA43 CAA43 expressed in pDHC29, CmR This study
pACLYC crtE, crtI, and crtB from Erwinia herbicola cloned
in pACYC184
(Cunningham et al. 1994)
pASK-IBA3-G6PD1 P1 isoform of Arabidopsis glucose-6-phosphate
dehydrogenase AtG6PD1 cloned in pASK-IBA3
(IBA, St. Louis, MO, USA), ApR
(Wakao and Benning 2005)
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OD475nm for lycopene concentration. A calibration curve
was made using lycopene standard (Sigma, St. Louis, MO).
The extinction coefficient used was 3.82 cm−1 L/mg.
Metabolite analysis by HPLC
Samples of 600 μL at each time point were taken and
centrifuged at 12,000 rpm for 1 min. The supernatants were
then filtered through a 0.2-μm syringe filter and aliquots were
subjected to HPLC analysis. To measure extracellular meta-
bolites, CAA43 substrate, 2- chloroacrylic acid and product,
2-chloropropionic acid, a HPLC system from Shimadzu
Scientific Instruments was used. Themetabolites were separated
by a cation-exchange column (HPX-87H, BioRad Labs, CA)
and quantified by a differential refractive index detector (Waters
2410, Milford, MA) and a UV–VIS detector (SPD-10A,
Shimadzu Scientific Instruments, Columbia, MD). The mobile
phase was 2.5 mM sulfuric acid and column was operated with
a flow rate of 0.5 mL/min at a constant temperature of 55 °C.
Results
To test that deletion of both PFK isoenzymes in E. coli will
increase NADPH bioavailability, we obtained pfkA pfkB
double null strain RL257 from the E. coli Genetic Stock
Center along with parent strain MQ, and the pfkA single
deletion strain, RL254, and the pfkB single deletion strain,
RL255. These four isogenic strains were confirmed
by growing in M9 minimal medium with glucose as the
sole carbon source. Consistent with the previous study
(Lovingshimer et al. 2006), MQ and the pfkB deletion strain,
RL255 grew well in minimal medium with 0.2 % glucose as
carbon source, while the pfkA pfkB double-deletion strain,
RL257 and the pfkA deletion strain, RL254 showed no or
little growth. This result is consistent with the fact that PfkA
contributes the majority of the PFK activity while PfkB
serves as the minor isoenzyme. Only when the major PFK
pfkA gene was deleted did we see a decreased growth.
To test the effect of the deletion of PFK activity on
NADPH-dependent biosynthesis, we first tested the deletion
strains on their ability to produce lycopene, which requires
16 mol of NADPH for 1 mol of product (Alper et al. 2005a).
pACLYC, carrying the crtE, crtB, and crtI, lycopene produc-
tion genes from E. herbicola was transformed into MQ,
RL257, RL254, and RL255, which resulted in testing strains
YW8055, 8056, 8057, and 8058, respectively. The strains
were grown in buffered LB medium with addition of 2 %
glucose for 24 to 48 h, lycopene was then extracted by acetone
and measured (Fig. 2) (Martinez et al. 2008). Results showed
that wild-type YW8055 consistently produced less lycopene
at 633 μg/L than the PFK null strain (pfkA pfkB) YW8056 at
1,055 μg/L. The pfkA single deletion strain, YW8057, showed
the highest concentration of lycopene at 4,330 μg/L, while the
pfkB single deletion, YW8058 had a concentration of lyco-
pene intermediate between that of the double-deletion strain,
YW8056 and the wild-type strain YW8055. The amount of
lycopene observed per glucose consumed (Fig. 2b) indicated
this value was highest for cultures of the pfkA mutant strain
followed by cultures of the double-deletion strain. This trend
stayed true when lycopene yields were compared based on dry
cell weight (DCW) (Fig. 2c).
In addition, we tested the combined effect of overexpression
of G6PDH and PFK deletion on NADPH bioavailability.
pASK-IBA3-G6PD1 carrying Arabidopsis G6PDH along with
the lycopene production plasmid, pACLYC were transformed
intoMQ, RL257, RL254, and RL255 resulting in testing strains
YW8082, YW8083, YW8084, and YW8085, respectively.
These strains were grown in buffered LB medium
supplemented with 2 % glucose, ampicillin 100 μg/mL, and
chloremphenicol 5 μg/mL for 24 to 66 h. At the end of the
culture, cells were collected and extracted for lycopene extrac-
tion. As shown in Fig. 3, after 66 h of growth, the double-
deletion strain, pfkA pfkB, produced the highest yield at 37 mg
lycopene/mole of glucose consumed, while the pfkB single
deletion strain produced the second highest yield at 24 mg of
lycopene/mole of glucose consumed, and the parent control
MQ and pfkA single deletion strain produced comparable and
the lowest yields of lycopene at 10 and 13mg lycopene/mole of
glucose consumed, respectively. Compared to the lycopene/ cell
amount or glucose consumed of the PFK deletion only strains,
additional overexpression of G6PDH did not increase lycopene
production. The same trend was also observed when lycopene
yields were compared based on DCWas shown in Fig. 3c.
Since we are re-routing the pathway glucose being oxi-
dized to PPP, to avoid the complexity caused by the pre-
cursors supplied by glycolytic pathway such as production
of lycopene, we examined a simplified system representa-
tive of a whole cell biocatalyst process. We also wanted to
use a situation where we could closely quantify the amount
of glucose consumed and the amount of reductant consumed
in the formation of the NADPH-requiring product compared
to the total amount of reductant generated by the cell. In this
experiment, we used anaerobic conditions so we could
assess the proportion of total reduced metabolism that
proceeded through the added heterologous NADPH con-
sumption system. This approach employed a one-step reac-
tion system using 2-haloacrylate reductase CAA43 which
was added to the PFK deletion strains. CAA43 from bacteria
Burkholderia sp. WS catalyzes a single-step reaction that
reduces 2-chloroacrylate to 2-chloropropionic acid using
NADPH as cofactor. CAA43 was first cloned in pTrc99A
under the Ptrc promoter, resulting in pTrc99A-CAA43. This
plasmid was then transformed into MQ, RL257, RL254, and
RL255, resulting in testing strains YW8051, 8052, 8053,
and 8054, respectively. These strains were first grown in LB
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medium, and CAA43 expression was induced by IPTG. The
cells were collected and resuspended in non-growing mini-
mal salts without nitrogen. The substrate of the one-step
reaction, 2-chloroacrylate was added at the same time at a
concentration of 50 mM, and the reactions were carried out
with the resuspended non-growing cells in a 37 °C shaker.
As shown in Fig. 4, the double-deletion strain, YW8052
showed the highest yield of 2-chloropropionic acid of 0.92
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Fig. 2 Lycopene production in
PFK-deficient strains. a
Lycopene concentration of
wild-type MQ and PFK single
or double-deletion strains.
Samples were taken after 26,
48, and 76 h growth in LB
supplemented with 2 % of
glucose under 30 °C and
250 rpm. b Lycopene
production of wild-type MQ
and PFK single or double-
deletion strains based on
glucose consumption. Samples
were taken after 26, 48, and
76 h growth in LB
supplemented with 2 % of
glucose under 30 °C and
250 rpm. c Lycopene
production (microgram) based
on dry cell weight (DCW) (g).
1 OD600nm=0.33 g DCW/L
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product/glucose (M/M), while the pfkA single deletion
strain, YW8053 had the second highest yield of 0.34
product/glucose (M/M), and the pfkB single deletion strain,
YW8054 and parent control strain YW8051 showed
comparable yields of 0.22 and 0.19 product/glucose
(M/M), respectively. In Fig. 4b, the proportion of reduction
equivalents that go toward formation of the reduced
2-chloropropionic acid compared to the total reduced
metabolites is calculated and presented to give a picture
of how much of the total reductant available is routed
through the added NADPH-requiring pathway. In the 6-h
determination, we see around 45 % of total reductant in the
double-deletion mutant strain goes to the reduction of the
2-chloroacrylate. The pfkA mutant is the next most efficient
with around 18 %, still significantly more than in the wild
type (∼11 %).
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Fig. 3 Combined effects of
G6PDH overexpression and
PFK deficiency on lycopene
production. a Lycopene
(microgram per liter) produced
by PFK-deficient strains
(YW8055, 8056, 8057, and
8058) and PFK-deficient strains
with coexpressed G6PDH
(YW8082, 8083, 8084, and
8085). pG6PDH refers to
pASK-IBA3-G6PD1. b
Lycopene production based on
glucose consumption for PFK-
deficient strains and PFK-
deficient strains with
overexpression of G6PDH. c
Lycopene production
(microgram) based on dry cell
weight (DCW) (g).
1 OD600nm=0.33 g DCW/L
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To test whether overexpression of G6PDHwill enhance PPP
and further increase the NADPH availability, we transformed
the plasmid expressingG6PDH fromArabidopsis together with
CAA43 into the set of PFK deletion strains. To be compatible
with the G6PDH plasmid, pASK-IBA3-G6PD1, the gene
encoding CAA43 was transferred to pDHC29. The testing
strains were therefore YW8066, 8067, 8068, 8069, 8070,
8071, 8072, and 8073 (Table 1). They were first grown in LB
medium and G6PDH was induced with anhydrotetracycline,
and CAA43 was induced with IPTG. As seen from Fig. 5,
overexpression of G6PDH indeed increased the yield calculat-
ed as product/glucose for the double-deletion strain, the pfkA
single deletion, and the pfkB single deletion strain. The most
pronounced increase was with the double-deletion PFK strain,
while the parental control showed a little lower yield compared
to that found without G6PDH overexpression.
Analyzing the metabolite profiles for this experiment, we
noticed that large amounts of lactate were produced as
byproduct, since we set up the CAA43 assay under anaerobic
conditions in order to be able to quantify the sources and
products of reduction reactions. To reduce the carbon and
reductant waste, we introduced a lactate dehydrogenase dele-
tion (ldh::kan) into the testing strains. However, after ldh was
deleted, the testing strains stopped using glucose (data not
shown). We speculate this is because without a healthy outlet
for NADH oxidation, the disruption of the NADH/NAD+
balance could not be entirely replaced by the NADPH sink
and caused the cells to stop glucose uptake.
Discussion
Regeneration of reduced cofactor has been an important
factor in enzyme based bioconversions such as reduction
of a carbonyl group to a chiral alcohol, which are often
important intermediates for pharmaceutical compounds.
Often such reductions employ NADPH, which is in short
supply in cells and can be a limiting factor in formation of
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high yields. This limitation has been addressed on a reaction
level by protein engineering of the enzyme from a NADPH-
requiring one to an NADH-utilizing enzyme. Other efforts
to supply NADPH at an enhanced level have used strategies
at the cellular level, including replacement of a NADH-
dependent reaction of glycolysis by a NADPH-dependent
one, rerouting more flux through the NADPH-generating
pentose phosphate pathway, or employing or removing
transhydrogenases. In this study, we focused on NADPH
generation through the pentose phosphate pathway (PPP).
By deleting the both PFK genes pfkA and pfkB in E. coli, the
glycolysis pathway was interrupted, while glucose was
forced to mainly go through the PPP to be oxidized, there-
fore more reducing equivalents in the form of NADPH
should be produced and be available for formation of re-
duced compounds requiring this specific cofactor.
Recent work has been published in examination of this
strategy but with somewhat different background strains and
using various compounds and pathways to evaluate the
effects on NADPH availability. NADPH-dependent biocon-
versions were studies by Walton and Stewart (2004), using
either a NADPH-dependent monooxygenase reaction or a
NADPH-dependent conversion of ethyl acetoacetate in non-
growing aerobic cells where yields of 2.3 mol of reduced
product per mole of glucose consumed were observed in the
latter case. Chin and Cirino (2011) examined combinations
of pfk mutations and transhydrogenase mutants on the pro-
duction of xylitol and aerobic experiments gave a high yield
of 5.4 mol/mol glucose with a sthA pfkA mutant. In other
recently reported studies, the reduction of methyl acetoacetate
by an alcohol dehydrogenase was analyzed in whole cell
biotransformations. The yield in a pgi mutant increased to
3.78 vs. 2.44 in the parent strain, and higher yields of 4.79
or 5.46 were reported in cells lacking phosphofructokinase I
or I and II, respectively (Siedler et al. 2011). This work was
followed by additional mutant studies where the authors con-
firmed by 13C metabolic flux analysis that partial cyclization
of the pentose phosphate pathway occurred, as we considered
in the experiments here. They also further extended the work
and found a higher glucose uptake rate in each of the host
strains examinedwhen a glucose facilitator and glucose kinase
system were added to the strains. In this case, the strains were
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based on the parent, E. coli BL21 Star (DE3) and pgi, pfkA,
pfkA pfkB derivatives were studied. To explain the differences
in the values seen in the experiments by other workers and in
this report, the different background hosts and the different
conditions examined are noted as well as the specific experi-
mental objectives of each report. The work we report is
consistent with these reports of increased flow through the
pentose phosphate pathway generating more availability of
NADPH.
Specifically in our tests of pfk mutants, we found unex-
pectedly that the pfkA single deletion strain produced more
lycopene and demonstrated a higher yield. In some cases
cited above, the double mutant was slightly improved over
the pfkA mutant; however, in those cases, the product was
not coupled to the formation of glycolytic intermediates.
Based on a previous study, except for NADPH, lycopene
production was also limited by its precursor, glyceraldehyde
3-phosphate (Farmer and Liao 2001). In the wild-type E.
coli, 1 mol of glucose generates 2 mol of glyceraldehyde
3-phosphate, while in a PFK null strain, 1 mol of glucose
would be expected to generate 1 mol of glyceraldehyde
3-phosphate while up to 3 mol of carbon are lost in the form
of CO2. For this reason, we speculate that even with extra
NADPH, the PFK null strain, YW8055 will not be able to
produce more lycopene due to limitations of the precursor,
glyceraldehyde 3-phosphate and its subsequent derived
product pyruvate which is also a substrate of DXP synthase.
The effects of low levels of these precursors and competi-
tion from other enzymes in the cell for these substrates make
postulating precise reasons for the effect difficult. Some
general thoughts are presented here on the relative impor-
tance of various factors. In the case of the pfkA single
deletion strain, the remaining PfkB can convert part of the
fructose-6-phosphate to fructose-1,6-biphosphate and allow
some flux down glycolysis to generate glyceraldehyde-3-
phosphate. At the same time, the rest of the fructose-6-
phosphate can be passed through the PPP and generate
NADPH. The flux distribution of fructose-6-phosphate in
pfkA single deletion strain was not measured in this study so
how much fructose-6-phosphate goes through glycolysis
through PfkB or how much goes through the PPP was not
determined. But the fact that the pfkA single deletion strain
showed the highest yield of lycopene lead us to consider the
possibility that in this particular strain the carbon flux dis-
tribution is more preferable for lycopene production with a
balanced ratio of precursor vs. NADPH required.
Glucose-6-phosphate dehydrogenase is the first enzyme
when glucose-6-phosphate enters the PPP, which converts
glucose-6-phosphate to 6-phosphoglucono-δ- lactone
with NADP+ as the electron acceptor. By overexpressing
G6PDH, the metabolic flux that goes to the PPP would be
expected to increase and NADPH production would there-
fore also be increased. E. coli G6PDH is regulated by
NADH level in the cell, so to avoid the inhibition, we chose
one isoform of G6PDH from Arabidopsis, G6PD1, which is
reported to be insensitive to redox changes (Wakao and
Benning 2005). However, we found further enhancement
of PPP by overexpressing Arabidopsis G6PDH did not
further increase the lycopene yield. Since lycopene produc-
tion may have also limited by precursor glyceraldehyde-3-
phosphate and pyruvate, this result may reflect a more
complicated metabolic situation.
To avoid the complication arising from use of the pre-
cursors from glycolysis in the analyzed product formation,
we developed a one-step reaction system utilizing CAA43
in order to have a better assessment of the NADPH bio-
availability. The CAA43 catalyzed reaction reduces 1 mol of
2-chloroacylic acid to 1 mol of 2-chloropropionic acid
coupled with oxidation of 1 mol of NADPH to NADP+
and neither of these compounds is normally produced or
acted upon by E. coli, we would be able to separate the use
of NADPH by this sink without direct effects on the usual
metabolites of the cell. The advantage of the single-step
reaction is that it directly reflects the bioavailability of
NADPH, and the biocatalysis was carried out under anaer-
obic conditions which allow us to quantify and calculate the
percentage of the reducing power in the form of NADPH
(the relative amount going to 2-chloropropionic acid) vs.
NADH (as measured by the amount of products arising from
NADH-dependent formation of lactate as the major product
and to a lesser extent the small quantities of ethanol and
succinate). The results shown here are consistent with our
view and previous work (Chin and Cirino 2011) that dele-
tion of PFK would increase the NADPH availability, espe-
cially when considering on a per glucose basis. For all the
reducing power generated by the cells, the PFK deletion
strains have more in the form of NAPDH. The results suggests
to us that modulation of the pfk genes can be used in applica-
tions to improve production of NADPH-dependent chemicals
and that fine tuning of this node along with consideration of
transhydrogenase contributions, and glucose uptake rates can
help in the design of processes for production of compounds
requiring NADPH reductive steps.
Acknowledgement This work was supported in part by National
Science Foundation CBET0828516. Y. Wang was partially supported
by a postdoctoral fellowship from the HHMI Beyond Traditional
Borders program and by a John S. Dunn Foundation Collaborative
Research Award. The authors want to thank Prof. Kurata for providing
plasmid pET101-D-topo-CAA43 and Prof. Benning for the gift of
pASK-IBA3-G6PD1.
Appl Microbiol Biotechnol
References
Alper H, Jin YS, Moxley JF, Stephanopoulos G (2005a) Identifying
gene targets for the metabolic engineering of lycopene biosynthe-
sis in Escherichia coli. Metab Eng 7(3):155–164. doi:10.1016/
j.ymben.2004.12.003
Alper H, Miyaoku K, Stephanopoulos G (2005b) Construction of
lycopene-overproducing E. coli strains by combining systematic
and combinatorial gene knockout targets. Nat Biotechnol
23(5):612–616. doi:10.1038/nbt1083
Bartek T, Blombach B, Zonnchen E, Makus P, Lang S, Eikmanns BJ,
Oldiges M (2010) Importance of NADPH supply for improved L-
valine formation in Corynebacterium glutamicum. Biotechnol
Prog 26(2):361–371. doi:10.1002/btpr.345
Chemler JA, Fowler ZL, McHugh KP, Koffas MA (2010) Improving
NADPH availability for natural product biosynthesis in Escherichia
coli by metabolic engineering. Metab Eng 12(2):96–104.
doi:10.1016/j.ymben.2009.07.003
Chin JW, Cirino PC (2011) Improved NADPH supply for xylitol
production by engineered Escherichia coli with glycolytic muta-
tions. Biotechnol Prog 27(2):333–341. doi:10.1002/btpr.559
Chin JW, Khankal R, Monroe CA, Maranas CD, Cirino PC (2009)
Analysis of NADPH supply during xylitol production by
engineered Escherichia coli. Biotechnol Bioeng 102(1):209–
220. doi:10.1002/bit.22060
Cunningham FX, Jr., Sun Z, Chamovitz D, Hirschberg J, Gantt E
(1994) Molecular structure and enzymatic function of lycopene
cyclase from the cyanobacterium Synechococcus sp strain
PCC7942. Plant Cell 6(8):1107–1121. doi:10.1105/tpc.6.8.1107
Farmer WR, Liao JC (2001) Precursor balancing for metabolic engi-
neering of lycopene production in Escherichia coli. Biotechnol
Prog 17(1):57–61. doi:10.1021/bp000137t
Kim S, Lee CH, Nam SW,Kim P (2011a) Alteration of reducing powers in
an isogenic phosphoglucose isomerase (pgi)-disrupted Escherichia
coli expressing NAD(P)-dependent malic enzymes and NADP-
dependent glyceraldehyde 3-phosphate dehydrogenase. Lett Appl
Microbiol 52(5):433–440. doi:10.1111/j.1472-765X.2011.03013.x
Kim YM, Cho HS, Jung GY, Park JM (2011b) Engineering the pentose
phosphate pathway to improve hydrogen yield in recombinant
Escherichia coli. Biotechnol Bioeng 108(12):2941–2946.
doi:10.1002/bit.23259
Kurata A, Kurihara T, Kamachi H, Esaki N (2005) 2-Haloacrylate
reductase, a novel enzyme of the medium chain dehydrogenase/
reductase superfamily that catalyzes the reduction of a carbon-
carbon double bond of unsaturated organohalogen compounds. J
Biol Chem 280(21):20286–20291. doi:10.1074/jbc.M414605200
Kurata A, Fujita M, Mowafy AM, Kamachi H, Kurihara T, Esaki N
(2008) Production of (S)-2-chloropropionate by asymmetric re-
duction of 2-chloroacrylate with 2-haloacrylate reductase coupled
with glucose dehydrogenase. J Biosci Bioeng 105(4):429–431.
doi:10.1263/jbb.105.429
Lee WH, Park JB, Park K, Kim MD, Seo JH (2007) Enhanced
production of epsilon-caprolactone by overexpression of NADPH-
regenerating glucose 6-phosphate dehydrogenase in recombinant
Escherichia coli harboring cyclohexanone monooxygenase gene.
Appl Microbiol Biotechnol 76(2):329–338. doi:10.1007/s00253-
007-1016-7
Lovingshimer MR, Siegele D, Reinhart GD (2006) Construction of an
inducible, pfkA and pfkB deficient strain of Escherichia coli for
the expression and purification of phosphofructokinase from bac-
terial sources. Protein Expr Purif 46(2):475–482. doi:10.1016/
j.pep.2005.09.015
Martinez I, Zhu J, Lin H, Bennett GN, San KY (2008) Replacing
Escherichia coli NAD-dependent glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) with a NADP-dependent enzyme from
Clostridium acetobutylicum facilitates NADPH dependent path-
ways. Metab Eng 10(6):352–359. doi:10.1016/j.ymben.2008.
09.001
Phillips GJ, Park SK, Huber D (2000) High copy number plasmids
compatible with commonly used cloning vectors. Biotechniques
28(3):400–402, 404, 406 passim
Sanchez AM, Andrews J, Hussein I, Bennett GN, San KY (2006) Effect
of overexpression of a soluble pyridine nucleotide transhydrogenase
(UdhA) on the production of poly(3-hydroxybutyrate) in
Escherichia coli. Biotechnol Prog 22(2):420–425. doi:10.1021/
bp050375u
Siedler S, Bringer S, Bott M (2011) Increased NADPH availability in
Escherichia coli: improvement of the product per glucose ratio in
reductive whole-cell biotransformation. Appl Microbiol
Biotechnol 92(5):929–937. doi:10.1007/s00253-011-3374-4
Siedler S, Bringer S, Blank LM, Bott M (2012) Engineering yield and
rate of reductive biotransformation in Escherichia coli by partial
cyclization of the pentose phosphate pathway and PTS-independent
glucose transport. Appl Microbiol Biotechnol 93(4):1459–1467.
doi:10.1007/s00253-011-3626-3
Vinopal RT, Clifton D, Fraenkel DG (1975) PfkA locus of Escherichia
coli. J Bacteriol 122(3):1162–1171
Wakao S, Benning C (2005) Genome-wide analysis of glucose-6-
phosphate dehydrogenases in Arabidopsis. Plant J 41(2):243–
256. doi:10.1111/j.1365-313X.2004.02293.x
Walton AZ, Stewart JD (2004) Understanding and improving NADPH-
dependent reactions by nongrowing Escherichia coli cells.
Biotechnol Prog 20(2):403–411. doi:10.1021/bp030044m
Yoon KW, Doo EH, Kim SW, Park JB (2008) In situ recovery of
lycopene during biosynthesis with recombinant Escherichia
coli. J Biotechnol 135(3):291–294. doi:10.1016/j.jbiotec.
2008.04.001
Appl Microbiol Biotechnol
